Skip to main content
. 2023 Feb 26;12(5):1852. doi: 10.3390/jcm12051852

Figure 1.

Figure 1

Proposed therapeutic strategies for NAFLD. AHA—American Heart Association; CMA—combined metabolic activator; FLiO—Fatty Liver in Obesity; UDCA—ursodeoxycholic acid.